Marketing-authorisation holder · United States
Pai Holdings Pharm
22 medicines in 1 country, as authorisation holder.
Group structure
Part of
PAIPharmaceutical groupOther companies in the group
Canada1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
22 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AQUAMEPHYTON10MG/ML ***Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1MG/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Phytonadione | United States | Not marketed | 1960 |
| CEFOTAN IN PLASTIC CONTAINER20mg base/ml | 40mg base/ml · Injectable | Cefotetan | United States | Not marketed | 1993 |
| DEXCHLORPHENIRAMINE MALEATE2MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Syrup | Dexclorfeniramina | United States | Not marketed | 1984 |
| ERYTHROMYCIN1.5% | 2% · Solution | Erythromycin | United States | Marketed | 1980 |
| FORTAZ1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 6GM/VIAL ** · Injectable | Ceftazidime | United States | Not marketed | 1985 |
| FORTAZ IN PLASTIC CONTAINER10mg base/ml | 20mg base/ml | 40mg base/ml · Injectable | Ceftazidime | United States | Not marketed | 1989 |
| LACTULOSE10gm/packet | 20gm/packet · For solution | Lactulose | United States | Marketed | 1997 |
| NORFLEX30MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Orphenadrine (citrate) | United States | Not marketed | 1960 |
| OXCARBAZEPINE300mg/5ml · Suspension | Oxcarbazepine | United States | Marketed | 2009 |
| PEDIAPRED5mg base/5ml · Solution | Prednisolone | United States | Marketed | 1986 |
| PENTAMIDINE ISETHIONATE300mg/vial · For solution | Pentamidine isethionate | United States | Marketed | 2019 |
| PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE5mg/5ml; 6.25mg/5ml · Syrup | Phenylephrine, Promethazine | United States | Marketed | 2006 |
| PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE10mg/5ml; 5mg/5ml; 6.25mg/5ml · Syrup | Codeine, Phenylephrine, Promethazine | United States | Marketed | 2006 |
| PROMETHAZINE DM15mg/5ml; 6.25mg/5ml · Syrup | Dextromethorphan, Promethazine | United States | Marketed | 2006 |
| SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE1.6gm/bot; 3.13gm/bot; 17.5gm/bot · Solution | Magnesium sulfate, Potassium sulfate, Sodium sulfate | United States | Marketed | 2017 |
| TENSILON10MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Edrophonium | United States | Not marketed | 1951 |
| TENSILON PRESERVATIVE FREE10MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Edrophonium | United States | Not marketed | 1951 |
| ZANTAC25MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Ranitidine | United States | Not marketed | 1984 |
| ZANTAC IN PLASTIC CONTAINER1mg base/ml | 50mg base/100ml · Injectable | Ranitidine | United States | Not marketed | 1986 |
| ZINACEF750MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Cefuroxime | United States | Not marketed | 1983 |
| ZINACEF1.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 7.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Cefuroxime | United States | Not marketed | 1983 |
| ZINACEF IN PLASTIC CONTAINER15mg base/ml | 30mg base/ml · Injectable | Cefuroxime | United States | Not marketed | 1989 |